|
⚲
|
| Elixir Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001175784 |
| Sale | 2009-05-15 ($25.0 M Offered, $12.0 M Sold) |
| Fund | |
| Phone | 6179957000 |
| Address | 12 Emily Street Cambridge, 02139 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Paul Martha | |
| Peter Distefano | |
| Vaughn Kailian | |
| Ansbert Gadicke | |
| Kenneth Greenberg | |
| Karen Roberts | |
| Robert Kriebel | |
| Dion Madsen | |
| Vernon Cassin |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Largey David
✚
|
0.0 | |
|
Belew Alisa Jane
✚
|
0.0 | |
|
Bella Costa Designs Inc
✚
|
0.0 | |
|
Bellaire Apartments Lawton, LLC
✚
|
0.0 | |
|
Bella Ray Beverage LLC
✚
|
0.0 | |
|
Bellarine Enterprise Ltd
✚
|
0.0 | |
|
Bell Bryan S
✚
|
0.0 | |
|
Bell Copper Corp
✚
|
0.0 | |
|
Laredo Regional Medical Center LP
✚
|
0.0 | |
|
CMTG Investor, L.P.
✚
|
0.0 |